Iovance Biotherapeutics Raises Full Year 2026 Revenue Guidance to $410 to $420 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| (NASDAQ: IOVA) | Delayed: 14.62 -0.24 (1.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.86 | 52 Week High | $ | |||
| Open | $14.95 | 52 Week Low | $ | |||
| Day High | $15.37 | P/E | N/A | |||
| Day Low | $14.59 | EPS | $ | |||
| Volume | 10,971,721 | |||||
